METTL3 and type 2 diabetes mellitus: In patients with type 2 diabetes (T2D), m6A levels were reduced, while the mRNA levels of FTO, METTL3, METTL14, WTAP were significantly elevated and involved in the pathogenesis of diabetes (51).